Share This Page
Drug Price Trends for OSCIMIN
✉ Email this page to a colleague
Average Pharmacy Cost for OSCIMIN
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OSCIMIN 0.125 MG TABLET | 68047-0252-01 | 0.14488 | EACH | 2024-12-18 |
| OSCIMIN SL 0.125 MG TABLET | 68047-0253-01 | 0.17465 | EACH | 2024-12-18 |
| OSCIMIN 0.125 MG TABLET | 68047-0252-01 | 0.09933 | EACH | 2024-11-20 |
| OSCIMIN SL 0.125 MG TABLET | 68047-0253-01 | 0.14788 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Oscimin
Overview of Oscimin
Oscimin, containing the active ingredient hyoscyamine sulfate, is an anticholinergic/antispasmodic medication. It is used to treat various functional intestinal disorders, reduce symptoms of mild dysenteries and diverticulitis, and control gastric secretion, visceral spasm, and hypermotility in several conditions[1][4].
Market Demand
The demand for Oscimin is driven by the need for effective treatments for gastrointestinal disorders, biliary and renal colic, and acute rhinitis. Given its broad range of indications, the market demand is likely to remain stable or increase, especially in populations with high prevalence rates of these conditions.
Competitive Landscape
The anticholinergic market is not highly competitive for specific formulations like Oscimin, as it is a niche product. However, the overall anticholinergic market includes other drugs that may serve similar purposes, such as atropine and other belladonna alkaloids. The lack of direct competitors for Oscimin suggests a relatively stable market position, but it must compete with other treatment options for gastrointestinal disorders.
Pricing Trends
General Drug Price Inflation
The overall drug price inflation rate is forecasted to continue its upward trend, with a projected rate of 3.78% for the calendar year starting July 1, 2023. This trend is driven by increases in prices and utilization[3].
Specific to Oscimin
Given that Oscimin is a specific formulation of hyoscyamine sulfate, its pricing is less likely to be significantly impacted by the introduction of biosimilars, which are more relevant to biologic drugs like adalimumab. However, any increase in the cost of raw materials, manufacturing, or distribution could lead to a price increase.
Price Projections
Short-Term Projections
In the short term, the price of Oscimin is likely to follow the general trend of drug price inflation. A modest increase of around 3-4% can be expected, aligning with the overall drug price inflation rate.
Long-Term Projections
Long-term price projections for Oscimin will depend on several factors, including changes in manufacturing costs, regulatory environment, and market demand. If the demand for anticholinergic treatments remains steady or increases, and there are no significant changes in the cost structure, the price of Oscimin could continue to rise at a rate slightly above the general inflation rate.
Factors Influencing Pricing
Regulatory Environment
Changes in regulatory policies or the approval of new drugs that treat similar conditions could impact the pricing of Oscimin. However, given its specific indications and lack of direct competitors, regulatory changes are less likely to have a significant immediate impact.
Market Dynamics
Payer preferences and healthcare system policies can influence the utilization and pricing of drugs. If payers prefer or mandate the use of certain anticholinergic drugs over others, it could affect the market share and pricing of Oscimin[3].
Economic Factors
Economic conditions, such as inflation and changes in healthcare spending, will also influence the pricing of Oscimin. In times of economic instability, healthcare spending may be affected, which could lead to price adjustments.
Conclusion
The market analysis for Oscimin suggests a stable demand driven by its specific indications and relatively low competition. Price projections indicate a modest increase in the short term, following the general trend of drug price inflation. Long-term projections will depend on various factors including market demand, regulatory changes, and economic conditions.
Key Takeaways
- Stable Demand: Oscimin's demand is driven by its effectiveness in treating gastrointestinal disorders and other specific conditions.
- Pricing Trends: Expected to follow the general drug price inflation rate of around 3-4% in the short term.
- Competitive Landscape: Relatively stable with few direct competitors.
- Regulatory and Economic Factors: Changes in these areas could impact long-term pricing.
FAQs
What is Oscimin used for?
Oscimin is used to treat functional intestinal disorders, reduce symptoms of mild dysenteries and diverticulitis, control gastric secretion, visceral spasm, and hypermotility in several conditions, and provide symptomatic relief for biliary and renal colic and acute rhinitis[1][4].
How does Oscimin work?
Oscimin works by competitively and non-selectively antagonizing muscarinic receptors in the smooth muscle, cardiac muscle, and other tissues, leading to reduced peristalsis, gastric secretions, and other effects[1][4].
What are the potential side effects of Oscimin?
Common side effects include dry mouth, blurred vision, urinary retention, and constipation. Serious side effects can include glaucoma, obstructive uropathy, and severe ulcerative colitis[1].
Can Oscimin be used in children?
Oscimin is not recommended for use in children under twelve years of age due to potential serious side effects[1].
How is Oscimin administered?
Oscimin is administered orally, with a typical dosage of 1 to 2 tablets three or four times a day, thirty minutes to one hour before meals and at bedtime[1].
Sources
- Drugs.com: Oscimin Tablet: Package Insert / Prescribing Information.
- Washington State Pharmacy and Therapeutics Committee: Outcome data on CGRP inhibitors.
- AJMC: Drug Prices to Continue Upward Trend Even as Biosimilars Enter the Market.
- DrugBank: Hyoscyamine: Uses, Interactions, Mechanism of Action.
More… ↓
